Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
Shannon Parisotto
Advertisement
Shannon Parisotto, MBA, is the corporate senior vice president of Charles River Laboratories.
Articles by Shannon Parisotto
Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
Advertisement
Latest Updated Articles
Toxicology: Ensuring Drugs are Safe for PeoplePublished: February 2nd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
